Channel Your Inner Martha and Turn a “Lemon Year” into Meyer Lemon Gummies with New CBD Sampler

 Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), a world-leading diversified cannabis, hemp, and cannabis device company, has released a highly giftable Martha Stewart CBD Wellness Gummies Sampler just in time for the holidays. Inspired by the French confection pâte de fruits, this elegant 60-count sampler box features 15 seasonal flavors such as Passionfruit, Calamondin and Quince.


Said Martha Stewart, “Holiday gift giving and receiving should be a joyous and fun occasion. In my experience, the gifts that are most appreciated are both luxurious and practical. Presented in a special gift box, my gummy sampler tastes like an elegant and delicious treat which delivers all the wellness benefits of CBD, making it the perfect way to indulge your loved ones, or yourself, without spending a fortune.”

Each Martha Stewart CBD Gummies Sampler includes 60 delectable 10mg CBD wellness gummies, featuring taste profiles found in Martha’s favorite holiday recipes. The full list of flavors includes: Black Currant, Black Raspberry, Blood Orange, Calamondin, Pink Grapefruit, Green Apple, Huckleberry, Kumquat, Meyer Lemon , Passion Fruit, Persian Lime, Quince, Red Raspberry, Rhubarb and Strawberry.

“With this special gummy sampler gift box, I was inspired by flavors from my garden,” said Stewart. She added, “Our celebrations may look a little different this year, but that doesn’t make the season any less special. A thoughtful, useful gift like our CBD collection is easy to shop for online without leaving home.”

This special edition Martha Stewart CBD gift box retails for $64.99 and is available for pre-order on November 11 at Canopy Growth’s one-stop ecommerce destination , ShopCanopy.com , with shipping to begin on November 27 .

“For decades, people have turned to Martha Stewart for advice on good living and tasteful giving, particularly during the holidays,” added Sol Clahane , VP and Managing Director, US, Canopy Growth. “We’re proud to partner with Martha and Marquee Brands to help bring Martha’s vision for this very special CBD wellness gummy sampler to life with an array of truly unique and very delicious flavors unlike anything else on the market. It’s a timely addition to her already popular line of CBD wellness products.”

The expanded portfolio of natural, gourmet flavored wellness gummies are specially formulated by Martha Stewart, in collaboration with the cannabinoid scientists at Canopy Growth, to deliver a delicious and consistent daily dose of pure, premium CBD isolate. The products are naturally flavored and are made in the USA with hemp-derived CBD isolate. The results are pure, safe, and great-tasting CBD products that are easy to incorporate into your daily wellness routine.

In addition to this special edition holiday gift, consumers can choose from a full range of Martha Stewart CBD products including 30-count gummies in Citrus Medley or Berry Medley , oil drops in Blood Orange, Meyer Lemon or Unflavored, and soft gels.

For more information, or to purchase Martha Stewart CBD, visit www.marthastewartcbd.com .

About Canopy Growth Corporation
Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.

Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.

From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen , breeding legends DNA Genetics and Green House Seeds, as well as lifestyle guru Martha Stewart and Fortune 500 alcohol leader Constellation Brands, to name but a few. For more information visit www.canopygrowth.com .

About Marquee Brands
Marquee Brands is a leading global brand owner and marketer. Owned by investor funds managed by Neuberger Berman, one of the world’s leading employee-owned investment managers, Marquee Brands targets high quality brands with strong consumer awareness and long-term growth potential. Marquee Brands seeks to identify brands in various consumer product segments with the goal of expanding their reach across retail channel, geography and product category while preserving the brand heritage and enhancing the ultimate consumer experience. Through its global team of professionals and partners, Marquee Brands monitors trends and markets in order to grow and manage brands in partnership with retailers, licensees and manufacturers through engaging, impactful strategic planning, marketing, and e- commerce. www.marqueebrands.com . In 2019, Marquee Brands acquired the Martha Stewart brand, which reaches approximately 100 million consumers across all media and merchandising platforms each month. Martha Stewart is the Founder of Martha Stewart Living Omnimedia and America’s most trusted lifestyle expert and teacher. Her branded products can be found in over 70 million households and have a growing retail presence in thousands of locations.

Notice Regarding Forward Looking Statements
This press release contains “forward-looking statements” and “forward-looking information” within the meaning of applicable U.S. and Canadian securities laws (collectively, “forward-looking statements”), which involve certain known and unknown risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of our investments. These forward-looking statements are generally identified by their use of such terms and phrases as “intend,” “goal,” “strategy,” “estimate,” “expect,” “project,” “projections,” “forecasts,” “plans,” “seeks,” “anticipates,” “potential,” “proposed,” “will,” “should,” “could,” “would,” “may,” “likely,” “designed to,” “foreseeable future,” “believe,” “scheduled” and other similar expressions. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Forward–looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those forward–looking statements and the forward–looking statements are not guarantees of future performance. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. A discussion of some of the material factors applicable to Canopy Growth Corporation (“Canopy”) can be found under the section entitled “Risk Factors” in Canopy’s Annual Report on Form 10-K for the year ended March 31, 2020, filed with the Securities and Exchange Commission and with applicable Canadian securities regulators, as such factors may be further updated from time to time in its periodic filings with the Securities and Exchange Commission and with applicable Canadian securities regulators, which can be accessed at www.sec.gov/edgar and www.sedar.com , respectively. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the filings. Any forward–looking statement included in this press release is made as of the date of this press release and, except as required by law, Canopy disclaims any obligation to update or revise any forward– looking statement. Readers are cautioned not to put undue reliance on any forward–looking statement. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Cision View original content to download multimedia: http://www.prnewswire.com/news-releases/martha-stewart-releases-delicious-15-flavor-cbd-wellness-gummy-holiday-sampler–in-collaboration-with-canopy-growth-corporation-and-marquee-brands-301170082.html

SOURCE Canopy Growth Corporation

News Provided by Canada Newswire via QuoteMedia

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less